{"database": "openregs", "table": "documents", "rows": [["FDA-2016-E-2528-0007", "FDA", "FDA-2016-E-2528", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; BRIVIACT ORAL TABLETS, New Drug Application 205836", "Notice", "Determinations", "2019-12-12T05:00:00Z", 2019, 12, "2019-12-12T05:00:00Z", "2020-02-11T04:59:59Z", "2019-12-12T14:29:37Z", "2019-26813", 0, 0, "0900006484206ad6"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-E-2528-0007"], "units": {}, "query_ms": 41.54749494045973, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}